Christentum Wochenende Shipley kappa and lambda free light chains in hemodialysis patients Stichprobe Zwietracht Charakterisieren
Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study | Blood Cancer Journal
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
JCM | Free Full-Text | Free Light Chains, High Mobility Group Box 1, and Mortality in Hemodialysis Patients
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease | PLOS ONE
PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Table 2 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients - Kidney International Reports
The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease | BMC Nephrology | Full Text
JCM | Free Full-Text | The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis
Removal of free light chains in hemodialysis patients without multiple myeloma: a crossover comparison of three different dialyzers – topic of research paper in Biological sciences. Download scholarly article PDF and read
Polyclonal free light chains: promising new biomarkers in inflammatory | CBF
The pathogenesis of renal injury and treatment in light chain deposition disease | Journal of Translational Medicine | Full Text
The biology of immunoglobulin free light chains and kidney injury - ScienceDirect
The biology of immunoglobulin free light chains and kidney injury - ScienceDirect
Measuring Serum Free Light Chains (FLC) Improves Diagnosis and Prognosis for Patients with Monclonal Gammopathies - Warde Medical Laboratory
Curing Cast Nephropathy by Removing Not-so-light Chains? — NephJC
Quantitative Assessment of Serum and Urinary Polyclonal Free Light Chains in Patients with Chronic Kidney Disease | American Society of Nephrology
Quantitative Assessment of Serum and Urinary Polyclonal Free Light Chains in Patients with Chronic Kidney Disease | American Society of Nephrology
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
Serum Free Light Chains and the Risk of ESRD and Death in CKD Article
Polyclonal free light chains: promising new biomarkers in inflammatory | CBF
Efficient Removal of Immunoglobulin Free Light Chains by Hemodialysis for Multiple Myeloma: In Vitro and In Vivo Studies | American Society of Nephrology
Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure | BMC Nephrology | Full Text
Effectiveness of Haemodiafiltration with Heat Sterilized High-Flux Polyphenylene HF Dialyzer in Reducing Free Light Chains in Patients with Myeloma Cast Nephropathy | PLOS ONE